DiaCue is a flagship rapid point-of-care diagnostic kit by BabyCue—a DPIIT-recognized healthtech innovator incubated at KIIT-TBI. Designed to eliminate diagnostic guesswork, support antibiotic stewardship, and protect patient gut health.
Impact
reduction in unnecessary antibiotic prescriptions in pilot programs
result vs. 24–48 hours in a traditional laboratory setting
lives reached through early screening and diagnostic support programs
linked to delayed or missed diagnosis - WHO
of rural India lacks access to basic diagnostic support
empirical prescribing of antibiotics accelerates global drug resistance
The Problem
In rural and semi-urban India, acute diarrhea is a leading cause of childhood illness. Yet, clinicians have no rapid, affordable tool to determine whether an infection is bacterial or viral.
Without immediate diagnostic support, doctors default to prescribing broad-spectrum antibiotics to protect against potential complications. This empirical prescribing fuels the rise of antimicrobial resistance (AMR)—one of the WHO's top global health threats.
To bridge this critical tools gap, we designed DiaCue—a point-of-care rapid test that gives clinicians actionable answers in minutes, shifting the paradigm from reactive guessing to targeted treatment.
Technology
DiaCue is designed to operate seamlessly in diverse clinical environments, from city hospitals to rural primary health centers.
Enables rapid, data-driven clinical decisions directly at the point of care during the patient visit.
Requires no cold-chain storage, complex instruments, or centralized laboratory infrastructure.
Differentiates bacterial from viral cases, providing objective evidence to support targeted prescribing.
Performance rigorously validated across multi-center field studies with pediatric and adult cohorts.
Clinical Validation
DiaCue has been evaluated in rigorous validation studies to ensure accuracy at the point of care.
Our Story
DiaCue was not conceived in a conference room—it was shaped by months of clinical immersion in rural Odisha.
BIRAC SPARSH Fellowship
During the BIRAC SPARSH Fellowship, our founding team embedded in primary and community health centers (PHCs and CHCs) across rural Odisha. They discovered that doctors possessed ample clinical knowledge but lacked point-of-care diagnostic tools to act on it.
Empirical Defaulting
Without rapid diagnostic results, and with laboratory stool cultures taking 24 to 48 hours, clinicians defaulted to broad-spectrum antibiotics for diarrheal cases. This empirical treatment led to unnecessary prescriptions and escalated AMR risks.
DiaCue Development
DiaCue was developed to bridge this gap. Designed directly from field evidence and in collaboration with clinicians, the lateral flow assay kit delivers a clear diagnostic readout in 20 minutes, enabling targeted, timely prescribing.
Our diagnostic solutions and clinical impact are recognized by global accelerators, national award boards, and government bodies.
Participant in the global CARB-X program accelerating antibacterial R&D to combat drug-resistant bacteria.
Strategic partnership with the Health & Family Welfare Department for primary healthcare diagnostic integration.
Winner of the TCS Innovation Challenge and the TATA TCS Thematic Award for social healthcare impact.
Selected to present clinical study data and diagnostic breakthroughs at the AIIMS Healthcare Summit.
DPIIT Certified Innovator
Infosys Foundation Social Innovation
COEP Innovation Summit Winner
Global AMR Innovation Challenge Participant
Hospital Tech Summit Showcase
Medical Device Innovation Showcase
Incubated at KIIT Technology Business Incubator
Pharma Innovation Showcase
Team
An interdisciplinary team of clinicians, scientists, and engineers working together to improve gut health diagnostics.
.png)
M. Pharm (Hospital and Clinical Practice), BIRAC-SPARSH SIIP Innovation Fellow, SIB Bio Design Fellow. Leading BabyCue's mission to transform digestive health solutions through precision diagnostics.
M.Sc (Microbiology). Manages administrative operations, strategic planning, and organizational development to ensure smooth execution of BabyCue's healthcare initiatives.
.png)
PhD (Life Sciences). Leads scientific research, product development, and clinical validation studies. Drives innovation in diagnostic technology and AI-powered health analytics.
.png)
M.Tech (Biotechnology). Leads R&D initiatives, product innovation, and technology development. Focuses on advancing diagnostic accuracy and AI integration.
B.Pharm. Supports clinical validation studies, field testing, and regulatory compliance. Ensures diagnostic accuracy and quality standards in clinical settings.
B.Tech (Computer Science). Sole engineer behind GI Bud. BabyCue's AI-powered gut health app. Leads mobile development, on-device ML integration, and cloud infrastructure.
Medical Advisors
.png)
HOD & Associate Professor, Department of Medical Devices, NIPER, Hyderabad. Expert in medical device development and regulatory compliance.
MD, PhD & Associate Professor, Department of Digestive Health, KIMS, Bhubaneswar. Specialist in digestive health care and clinical validation studies.
.png)
Co-founder & CEO, Sleepiz AG, Zurich, Switzerland. HealthTech entrepreneur and investor, providing strategic guidance and funding.
We are actively partnering with clinicians, researchers, and investors to expand our diagnostic and digital health programs across India.
Evaluate DiaCue in clinical workflows, help strengthen field validation, and support targeted prescribing in your facility.
Contact the clinical teamCollaborate on clinical studies, diagnostic innovation, antimicrobial stewardship pathways, and public health implementations.
Start a research discussionPartner with a DPIIT-recognized, government-incubated healthtech innovator to scale point-of-care diagnostics across India.
Contact investor relationsCONTACT
We work with clinical institutions, public health researchers, and investment partners. Share your details and our team will respond within 24 hours.